Search research articles
Contact Us
Filters
Showing results (131-140 of 141) with videos related to
Page
of 15
Sort By:
Annals of the New York Academy of Sciences
|
May 20, 2000
Corpus callosum measurement as an in vivo indicator for neocortical neuronal integrity, but not white matter pathology, in Alzheimer's disease
H Hampel, S J Teipel, G E Alexander, et al.
Acta Psychiatrica Scandinavica
|
August 1, 1992
Inadequate treatment response to des-enkephalin-gamma-endorphin compared with thioridazine and placebo in schizophrenia
S A Montgomery, M Green, R Rimon, et al.
Pharmacopsychiatry
|
January 1, 1993
Report on the Fourth Consensus Conference on the Methodology of Clinical Trials with Anxiolytic Drugs
J Angst, M Ansseau, P Bech, et al.
Pharmacopsychiatry
|
March 31, 2004
Blood dyscrasias induced by psychotropic drugs
S Stübner, R Grohmann, R Engel, et al.
Der Nervenarzt
|
January 1, 1970
[Usability of psychiatric diagnoses of the WHO diagnostic classification]
H J Bochnik, H Helmchen, H Hippius, et al.
Neurology
|
November 18, 1998
Dissociation between corpus callosum atrophy and white matter pathology in Alzheimer's disease
S J Teipel, H Hampel, G E Alexander, et al.
Neuropsychobiology
|
January 1, 1980
Antithymic immune factor in schizophrenia. A World Health Organization study
G Koliaskina, M Tsutsulkovskaya, I Domashneva, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
|
January 1, 1994
[The role of hereditary, clinical and pharmacokinetic factors in predicting the prophylactic effect of lithium salts]
M E Vartan'ian, G P Panteleeva, V A Gor'kov, et al.
Arzneimittel-Forschung
|
January 1, 1980
[Drug monitoring in psychiatry (author's transl)]
E Rüther, O Benkert, F Eckmann, et al.
Modern Problems of Pharmacopsychiatry
|
January 1, 1970
Definition and classification of neuroleptics
O H Arnold, J Collard, P Deniker, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 141) with videos related to
Sort By:
Page
of 15
Annals of the New York Academy of Sciences
|
May 20, 2000
Corpus callosum measurement as an in vivo indicator for neocortical neuronal integrity, but not white matter pathology, in Alzheimer's disease
H Hampel, S J Teipel, G E Alexander, et al.
Acta Psychiatrica Scandinavica
|
August 1, 1992
Inadequate treatment response to des-enkephalin-gamma-endorphin compared with thioridazine and placebo in schizophrenia
S A Montgomery, M Green, R Rimon, et al.
Pharmacopsychiatry
|
January 1, 1993
Report on the Fourth Consensus Conference on the Methodology of Clinical Trials with Anxiolytic Drugs
J Angst, M Ansseau, P Bech, et al.
Pharmacopsychiatry
|
March 31, 2004
Blood dyscrasias induced by psychotropic drugs
S Stübner, R Grohmann, R Engel, et al.
Der Nervenarzt
|
January 1, 1970
[Usability of psychiatric diagnoses of the WHO diagnostic classification]
H J Bochnik, H Helmchen, H Hippius, et al.
Neurology
|
November 18, 1998
Dissociation between corpus callosum atrophy and white matter pathology in Alzheimer's disease
S J Teipel, H Hampel, G E Alexander, et al.
Neuropsychobiology
|
January 1, 1980
Antithymic immune factor in schizophrenia. A World Health Organization study
G Koliaskina, M Tsutsulkovskaya, I Domashneva, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
|
January 1, 1994
[The role of hereditary, clinical and pharmacokinetic factors in predicting the prophylactic effect of lithium salts]
M E Vartan'ian, G P Panteleeva, V A Gor'kov, et al.
Arzneimittel-Forschung
|
January 1, 1980
[Drug monitoring in psychiatry (author's transl)]
E Rüther, O Benkert, F Eckmann, et al.
Modern Problems of Pharmacopsychiatry
|
January 1, 1970
Definition and classification of neuroleptics
O H Arnold, J Collard, P Deniker, et al.
Page
of 15